Elanor Investors Group Toekomstige groei

Future criteriumcontroles 0/6

Momenteel beschikken we niet over voldoende analisten om de groei en omzet voor Elanor Investors Group te voorspellen.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

Hospitality winstgroei	15.2%
Inkomstengroei	n/a
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	None
Laatst bijgewerkt	n/a

Recente toekomstige groei-updates

Recent updates

Elanor Investors Group (ASX:ENN) Will Pay A Dividend Of A$0.0475

Dec 22

There's Reason For Concern Over Elanor Investors Group's (ASX:ENN) Price

Dec 14

Shareholders May Be More Conservative With Elanor Investors Group's (ASX:ENN) CEO Compensation For Now

Oct 18

Elanor Investors Group (ASX:ENN) Use Of Debt Could Be Considered Risky

Jun 28

When Should You Buy Elanor Investors Group (ASX:ENN)?

Jun 16

These 4 Measures Indicate That Elanor Investors Group (ASX:ENN) Is Using Debt In A Risky Way

May 10

In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Elanor Investors Group onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.

Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.

Winst- en omzetgroeiprognoses

ASX:ENN - Toekomstschattingen van analisten en financiële gegevens uit het verleden (AUD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2023	147	-26	-69	10	N/A
9/30/2023	149	-21	-62	14	N/A
6/30/2023	151	-17	-55	18	N/A
3/31/2023	153	-15	-39	17	N/A
12/31/2022	154	-13	-24	16	N/A
9/30/2022	135	-13	-25	6	N/A
6/30/2022	115	-12	-27	-5	N/A
3/31/2022	106	-4	-19	-5	N/A
12/31/2021	97	4	-12	-5	N/A
9/30/2021	97	4	-2	5	N/A
6/30/2021	98	3	9	15	N/A
3/31/2021	85	0	-5	13	N/A
12/31/2020	72	-3	-20	12	N/A
9/30/2020	70	-7	-76	10	N/A
6/30/2020	69	-10	-133	7	N/A
12/31/2019	89	-11	-117	8	N/A
9/30/2019	106	-3	-64	5	N/A
6/30/2019	122	5	-12	3	N/A
12/31/2018	118	3	-5	1	N/A
9/30/2018	97	-2	-60	3	N/A
6/30/2018	76	-7	-116	5	N/A
12/31/2017	52	-2	-111	8	N/A
9/30/2017	59	0	N/A	10	N/A
6/30/2017	66	1	N/A	13	N/A
3/31/2017	91	1	N/A	13	N/A
12/31/2016	86	-1	N/A	13	N/A
9/30/2016	78	-1	N/A	13	N/A
6/30/2016	69	-1	N/A	14	N/A
3/31/2016	66	1	N/A	13	N/A
12/31/2015	62	2	N/A	12	N/A
9/30/2015	59	0	N/A	9	N/A
6/30/2015	56	-3	N/A	7	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er zijn onvoldoende gegevens om te bepalen of de verwachte winstgroei van ENN boven de spaarquote ( 2.6% ) ligt.

Winst versus markt: Er zijn onvoldoende gegevens om te bepalen of de winst van ENN naar verwachting sneller zal groeien dan de markt Australian

Hoge groeiwinsten: Er zijn onvoldoende gegevens om te bepalen of de winst van ENN naar verwachting de komende 3 jaar aanzienlijk zal groeien.

Omzet versus markt: Er zijn onvoldoende gegevens om te bepalen of de omzet van ENN naar verwachting sneller zal groeien dan de markt Australian.

Hoge groei-inkomsten: Er zijn onvoldoende gegevens om te bepalen of de omzet van ENN naar verwachting sneller zal groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van ENN naar verwachting over 3 jaar hoog zal zijn

Elanor Investors Group Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

Recente toekomstige groei-updates

Price target decreased by 18% to AU$1.76

Price target decreased to AU$2.36

Elanor Investors Group Provides Earnings Guidance for the Six Months Ending 31 December 2021

Price target increased to AU$2.46

Elanor Investors Group Provides Earnings Guidance for the Six Months Ending 30 June 2021

Price target raised to AU$2.03

Recent updates

Elanor Investors Group, Annual General Meeting, Nov 28, 2024

Elanor Investors Group and Elanor Funds Management Limited Announces Board Changes

Elanor Investors Group Announces Retirement of Glenn Willis as CEO

New minor risk - Financial data availability

Elanor Reportedly Taps Denison Partners for Hotel Sale

New major risk - Financial position

Now 76% overvalued

MD, CEO & Director recently bought AU$98k worth of stock

Now 23% undervalued after recent price drop

Price target decreased by 18% to AU$1.76

First half 2024 earnings released: AU$0.091 loss per share (vs AU$0.003 loss in 1H 2023)

High number of new directors

Elanor Investors Group (ASX:ENN) Will Pay A Dividend Of A$0.0475

Elanor Investors Group Provides Distribution Guidance for the Six Months Ending December 31, 2023, Payable on February 29, 2024

There's Reason For Concern Over Elanor Investors Group's (ASX:ENN) Price

Shareholders May Be More Conservative With Elanor Investors Group's (ASX:ENN) CEO Compensation For Now

Elanor Investors Group, Annual General Meeting, Oct 25, 2023

Elanor Investors Group Announces Board Changes

New minor risk - Financial position

Full year 2023 earnings: Revenues exceed analyst expectations

Elanor Investors Group Appoints Victor Rodriguez as A Non-Executive Director, Effective 7 July 2023

Elanor Investors Group (ASX:ENN) Use Of Debt Could Be Considered Risky

New minor risk - Shareholder dilution

First half 2023 earnings released: AU$0.034 loss per share (vs AU$0.009 profit in 1H 2022)

Elanor Investors Group (ASX:ENN) acquired Riverton Forum shopping centre in Perth for $98.8 million on December 21, 2022.

Elanor Hotel Accommodation Fund, managed by Elanor Investors Group (ASX : ENN) agreed to acquire Chateau Yering Hotel Management Pty Ltd.

Now 22% undervalued after recent price drop

Price target decreased to AU$2.36

Now 21% undervalued after recent price drop

Elanor Investors Group Announces Establishment of the Tweed Mall Mixed-Use Real Estate Fund

Elanor Investors Group, Annual General Meeting, Oct 27, 2022

Now 22% undervalued

Full year 2022 earnings released: AU$0.048 loss per share (vs AU$0.029 profit in FY 2021)

Now 21% undervalued after recent price drop

Now 24% undervalued after recent price drop

Elanor Investors Group Announces Distribution for the Six Month Ending June 30, 2022, Payable on August 31, 2022

When Should You Buy Elanor Investors Group (ASX:ENN)?

Now 21% undervalued after recent price drop

These 4 Measures Indicate That Elanor Investors Group (ASX:ENN) Is Using Debt In A Risky Way

Elanor Investors Group Announces the Establishment of the Harris Street Fund

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 20% undervalued after recent price drop

Elanor Investors Group Announces for the Six Months Ended December 31, 2021, Payable on February 28, 2022

Elanor Investors Group to Report First Half, 2022 Results on Feb 21, 2022

Now 20% undervalued

Upcoming dividend of AU$0.088 per share

Elanor Investors Group Provides Earnings Guidance for the Six Months Ending 31 December 2021

Full year 2021 earnings released: EPS AU$0.029 (vs AU$0.09 loss in FY 2020)

Price target increased to AU$2.46

Elanor Investors Group's (ASX:ENN) Earnings Aren't As Good As They Appear

Full year 2021 earnings released: EPS AU$0.039 (vs AU$0.10 loss in FY 2020)

Elanor Investors Group Provides Earnings Guidance for the Six Months Ending 30 June 2021

Elanor Investors Group (ASX:ENN) Has No Shortage Of Debt

Elanor Healthcare Real Estate Fund, managed by Elanor Investors Group (ASX:ENN) acquired Broadway Medical Centre in Ellenbrook for AUD 12 million.

Estimating The Intrinsic Value Of Elanor Investors Group (ASX:ENN)

What Is Elanor Investors Group's (ASX:ENN) Share Price Doing?

Is Elanor Investors Group (ASX:ENN) A Risky Investment?

Price target raised to AU$2.03

New 90-day low: AU$1.48

Non-Executive Director has left the company

Elanor Investors Group Announces Resignation of Kin Song Lim as a Non-Executive Director of Elanor Investors Group, Elanor Retail Property Fund and Elanor Commercial Property Fund

New 90-day high: AU$1.80

Elanor Healthcare Real Estate Fund, managed by Elanor Investors Group (ASX:ENN) acquired 2 Civic Boulevard property in Rockingham for AUD 22.9 million.

Elanor Investors Group (ASX:ENN) acquired Office Complex in Woolloongabba for for AUD 80.2 million.

Elanor Investors Group Establishes New Managed Fund, the Burke Street Fund

New 90-day high: AU$1.44

Elanor Healthcare Real Estate Fund, managed by Elanor Investors Group (ASX:ENN) acquired Woolloongabba Community Health Centre in Brisbane, Australia for AUD 37.3 million.

New 90-day high: AU$1.20

Riverside Plaza Syndicate fund of Elanor Investors Group (ASX:ENN) acquired Riverside Plaza in Queanbeyan from Vicinity Centres (ASX:VCX) for AUD 60 million.